Showing results (141-150 of 236) with videos related to
Sort By:
Pageof 24
Cancer Research|June 13, 2000
Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase inductionW Davis, A Hewer, K M Rajkowski, et al.Carcinogenesis|October 1, 1995
Formation and persistence of benzo[a]pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformationM Suh, F Ariese, G J Small, et al.Carcinogenesis|May 1, 1996
Tamoxifen does not form detectable DNA adducts in white blood cells of breast cancer patientsD H Phillips, A Hewer, P L Grover, et al.Carcinogenesis|May 1, 1988
Further metabolism of diol-epoxides of chrysene and dibenz[a,c]anthracene to DNA binding species as evidenced by 32P-postlabelling analysisM Hall, D K Parker, A J Hewer, et al.Nature|December 22, 1988
Correlation of DNA adduct levels in human lung with cigarette smokingD H Phillips, A Hewer, C N Martin, et al.Mutagenesis|March 3, 2010
Gender-related differences in response to mutagens and carcinogensM Kirsch-Volders, S Bonassi, Z Herceg, et al.Mutagenesis|July 1, 1989
DNA adduct formation by 7-methoxy-2-nitro-naphtho[2,1-b]furan (R7000), an extremely potent mutagenE Touati, D H Phillips, J P Buisson, et al.Mutagenesis|September 1, 1988
Activating mutations in human c-Ha-ras-1 gene induced by reactive derivatives of safrole and the glutamic pyrolysis product, Glu-P-3C M Ireland, C S Cooper, C J Marshall, et al.Cancer Research|October 16, 1999
Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabelingR L Divi, M R Osborne, A Hewer, et al.Cancer Research|January 1, 1996
Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifenM R Osborne, A Hewer, I R Hardcastle, et al.Pageof 24